Please note
This trial is no longer recruiting patients. We hope to add results when they are available.
Blood cancers, Myelofibrosis
Closed
Phase 3
This study is looking at a drug called ruxolitinib for myelofibrosis. It is for people who have certain high risk gene changes (mutations).
Recruitment start: 3 February 2016
Recruitment end: 19 April 2017
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Dr Tim Sommervaille
Novartis
Last reviewed: 02 May 2017
CRUK internal database number: 14473
About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education
What to ask your doctor about clinical trials.
Meet and chat to other cancer people affected by cancer.
Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.
